Abstract |
The purpose of this study was to compare the relative cost-effectiveness of florfenicol with that of tulathromycin for treatment of undifferentiated fever (UF) in feedlot calves at ultra-high risk of developing UF that receive metaphylactic tulathromycin on arrival at the feedlot. Calves that received therapeutic florfenicol had lower overall mortality (P=.045) and bovine respiratory disease mortality (P=.050) compared with calves that received therapeutic tulathromycin, but no significant differences were detected in feedlot performance, carcass characteristics, or other animal health variables. There was a net advantage of Can$41.19/treated animal in the florfenicol group versus the tulathromycin group. This study demonstrates that it is more cost-effective to use florfenicol than tulathromycin for the initial treatment of UF in feedlot calves at ultra-high risk of developing UF that receive on-arrival metaphylactic tulathromycin.
|
Authors | Tye Perrett, Sameeh M Abutarbush, Brian K Wildman, Maria T Fuchs, Oliver C Schunicht, Colleen M Pollock, R Kent Fenton, G Kee Jim, P Timothy Guichon, Calvin W Booker, Janice Berg, Joe Roder, Mark Spire |
Journal | Veterinary therapeutics : research in applied veterinary medicine
(Vet Ther)
Vol. 9
Issue 2
Pg. 128-40
( 2008)
ISSN: 1528-3593 [Print] United States |
PMID | 18597251
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Bacterial Agents
- Disaccharides
- Heterocyclic Compounds
- florfenicol
- Thiamphenicol
- tulathromycin
|
Topics |
- Animals
- Animals, Newborn
- Anti-Bacterial Agents
(economics, therapeutic use)
- Bovine Respiratory Disease Complex
(drug therapy, mortality)
- Cattle
- Cattle Diseases
(drug therapy, mortality)
- Cost-Benefit Analysis
- Disaccharides
(economics, therapeutic use)
- Fever
(drug therapy, mortality, veterinary)
- Heterocyclic Compounds
(economics, therapeutic use)
- Thiamphenicol
(analogs & derivatives, economics, therapeutic use)
- Treatment Outcome
|